+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ozempic"

Liraglutide and Semaglutide Market Report 2025 - Product Thumbnail Image

Liraglutide and Semaglutide Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Semaglutides Market Report 2025 - Product Thumbnail Image

Semaglutides Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
From
From
Anti-diabetic Drugs Market - Product Thumbnail Image

Anti-diabetic Drugs Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Ozempic (semaglutide) is a prescription medication used to treat type 2 diabetes. It belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists, which work by stimulating the release of insulin and reducing the amount of glucose produced by the liver. Ozempic is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes. It can also be used as an adjunct to other diabetes medications, such as metformin or sulfonylureas. Ozempic is part of a growing market of Endocrine and Metabolic Disorders Drugs, which includes medications used to treat a variety of conditions, such as obesity, thyroid disorders, and polycystic ovary syndrome. These drugs are used to help regulate hormones and metabolism, and can be used to improve overall health and quality of life. Companies in the Ozempic market include Novo Nordisk, Eli Lilly, Sanofi, Merck, and AstraZeneca. Show Less Read more